Skip to content
    FTV
    Earnings call· Jun 2026(Q2 FY26)

    Fortive Q2 FY26 earnings call FTV

    Jul 29, 2026 Source

    Executive summary

    Fortive Q2 FY26 — Strong Performance and Raised Full-Year Guidance

    Fortive delivered another quarter of strong financial performance, driven by its accelerated strategy focused on innovation, commercial execution, and recurring customer value. The company saw broad-based strength across segments, particularly in North America and APAC/LatAm, leading to a significant raise in full-year adjusted EPS guidance. Strategic capital allocation included share repurchases and a bolt-on acquisition, reinforcing confidence in its medium-term financial framework.

    Highlights

    5
    • Consolidated core revenue grew 6.7% year-over-year, driven by healthy customer demand and strong execution.

    • Adjusted EBITDA increased 12% year-over-year, expanding margin by 110 basis points to 29.5%.

    • Adjusted EPS grew 28% year-over-year to $0.74, marking the fourth consecutive quarter of double-digit growth.

    • Generated roughly $270 million of free cash flow in Q2, with trailing 12-month free cash flow topping $1 billion.

    • Raised full-year 2026 adjusted EPS guidance to $2.95-$3.05, reflecting solid first-half performance and business trajectory.

    Concerns

    3
    • Adjusted gross margin was 63%, down approximately 100 basis points year-over-year, primarily due to product mix dynamics.

    • Revenue in the Europe and Middle East and Africa region declined modestly due to macroeconomic uncertainty and economic softness.

    • Advanced Healthcare Solutions adjusted EBITDA margin contracted by about 80 basis points year-over-year to 26%.

    Guidance & targets

    14
    CategoryTargetConfidence
    Full-year 2026 Adjusted EPS
    $2.95 to $3.05
    high materiality
    High
    Full-year 2026 Reported Revenue
    approximately $4.35 billion
    medium materiality
    Medium
    Full-year 2026 Core Growth
    approximately 4%
    high materiality
    High
    Q3 Reported Revenue
    broadly in line with historical patterns
    low materiality
    Medium
    Q4 Reported Revenue Headwind
    $15 million to $20 million
    medium materiality
    High
    Q4 Core Growth Headwind
    150 basis points
    medium materiality
    High
    FX and M&A Reported Revenue Tailwind
    about a 50 basis point tailwind
    low materiality
    Medium
    Q3 Adjusted EBITDA Margins
    slightly below Q2 levels
    medium materiality
    Medium
    Q3 Effective Tax Rate
    mid-teens
    low materiality
    High
    Q4 Effective Tax Rate
    low double-digit range
    low materiality
    High
    Full-year Net Interest Expense
    about $140 million
    low materiality
    High
    Q3 Adjusted EPS
    up very slightly year-over-year
    medium materiality
    Medium
    Medium-term Financial Framework
    fully intact
    high materiality
    High
    Annualized EBITDA Margin Expansion
    50 to 100 basis points
    medium materiality
    High

    Segment performance

    2
    SegmentRevenueYoYQoQMargin
    Intelligent Operating Solutions (IOS)
    Broad momentum across the segment, with core growth driven by price and volume. Solid performance in professional instrumentation, facility and asset lifecycle solutions, and gas detection products. Fluke order volume remained strong, modestly outpacing revenue growth. North America was the strongest growth driver, with strong growth in APAC and LatAm offsetting macroeconomic uncertainty in Europe. Adjusted gross margin was just over 65%, down about 100 bps YoY, primarily due to strong growth in lower-margin products serving multisite retail customers, partially offset by operating leverage.
    Core revenue growth: 7.4%Adjusted EBITDA: $264MAdjusted EBITDA growth: 12%
    $750M9% reported35% adjusted EBITDA margin
    Advanced Healthcare Solutions (AHS)
    Growth driven by solid demand for healthcare consumables, services, and software in Latin America, APAC, and North America. Software products continued strong growth. Low-temperature sterilization capital demand improved modestly. Adjusted gross margin was roughly 58%, down about 110 bps YoY, reflecting product mix dynamics and strategic growth investments, partially offset by operating leverage.
    Core revenue growth: 5.3%Adjusted EBITDA: $88MAdjusted EBITDA growth: 3%
    $340M6% reported26% adjusted EBITDA margin

    Operational metrics

    18
    Consolidated Core Revenue Growth
    6.7%YoY
    Q2 FY26

    Reflects continued progress on driving faster profitable organic growth.

    Consolidated Adjusted EBITDA Growth
    12%YoY
    Q2 FY26

    Driven by adjusted gross profit growth, operating leverage, and discrete structural cost savings.

    Consolidated Adjusted EPS Growth
    28%YoY
    Q2 FY26

    Fourth consecutive quarter of double-digit adjusted EPS growth.

    Share Repurchases
    $200M
    Q2 FY26

    Part of disciplined capital allocation approach.

    Total Share Repurchases since Spin-off
    $2B
    Since spin-off

    Represents approximately 11% of diluted shares outstanding.

    Recurring Revenue Growth
    strong
    Q2 FY26

    Driven by strong performance in services and software offerings at Fluke, and consumables and services at ASP.

    IEEPA Tariff Refund Benefit
    $4.5M
    Q2 FY26

    Recognized in GAAP earnings; excluded from adjusted metrics. Expect another $20M-$25M in coming quarters.

    Gross Debt to Adjusted EBITDA
    2.7xmodestly delevering from last quarter
    Q2 FY26

    Balance sheet remains strong.

    Diluted Shares Outstanding
    307M
    Q2 FY26 end

    Result of continued focus on capital deployment.

    Consolidated Reported Revenue Growth
    8%YoY
    Q2 FY26

    Total revenue of nearly $1.1 billion.

    Consolidated Adjusted Gross Margin
    63%down 100 bps YoY
    Q2 FY26

    Primarily driven by product mix dynamics, partially offset by operating leverage.

    Consolidated Adjusted EBITDA Margin
    29.5%expanded 110 bps YoY
    Q2 FY26

    Driven by adjusted gross profit growth, operating leverage, and discrete structural cost savings.

    Consolidated Adjusted EPS
    $0.74up 28% YoY
    Q2 FY26

    Driven by growth in adjusted EBITDA and positive year-over-year impact of share repurchases.

    North America Growth
    strongest performing regionmodest sequential acceleration
    Q2 FY26

    Saw modest sequential acceleration in Q2.

    EMEA Revenue
    declined modestly
    Q2 FY26

    Due to macroeconomic uncertainty and continued economic softness.

    APAC and LatAm Growth
    strongsequential acceleration
    Q2 FY26

    Driven by strong demand for professional instrumentation and health care consumables.

    Fluke Order Volume
    strongmodestly outpacing revenue growth
    Q2 FY26

    Customer demand continues to be robust across industry-leading portfolio.

    Corporate Costs
    $26M to $27M
    Per quarter

    Expected range for corporate costs; Q2 had a step-up due to mark-to-market of incentive compensation.

    Industry KPIs

    6
    MetricValueDetails
    Tariff cost impact$4.5MUSD
    Parts aftermarket businessstrong performance
    Data center prime power demandstrong demand
    Dealer inventory months of supplymuch better inventory channel inventory position
    Incremental margin operating leverage110 bpsbps
    Order backlog order intake by segmentnicely above 1

    Orderbook & backlog

    1
    Fluke Book-to-Bill Rationicely above 1Q2 FY26

    Orders grew modestly faster than revenues.

    Product announcements

    3
    ProductTypeDetails
    CertiFiber Maxlaunch
    Flash AIlaunch
    ASP STERRAD (low temperature sterilization equipment)update

    Deals & partnerships

    1
    UV SmartAcquisition of majority stake in an innovative company with complementary UVC high-level disinfection technology.

    Completed towards the end of Q2 FY26. Execution of value creation plans for this and two small bolt-on acquisitions from Q4 FY25 are going according to plan.

    Risks & headwinds

    5
    Macroeconomic uncertainty and economic softness in EMEAQ2 FY26

    Revenue in the Europe and Middle East and Africa region declined modestly.

    Mitigation: Offset by strong growth in APAC and LatAm, driven by increased commercial investments.

    Product mix dynamics impacting gross marginQ2 FY26

    Consolidated adjusted gross margin down approximately 100 bps YoY to 63%; AHS adjusted gross margin down about 110 bps YoY to 58%; IOS adjusted gross margin down about 100 bps YoY to 65%.

    Mitigation: Partially offset by operating leverage and discrete structural cost savings. Management expects to continue driving price through innovation and commercial acceleration.

    Memory chip supply and rare earth availabilityOngoing

    Not a material factor impacting conversion rates at this point.

    Mitigation: Teams are actively working on countermeasures, including securing multiple sources for components.

    Fewer selling days in Q4 FY26Q4 FY26

    About a $15 million to $20 million headwind to reported revenue and a 150 basis point headwind to core growth.

    Mitigation: Factored into full-year guidance; management expects a better margin outlook in Q4 compared to Q3 despite this.

    More difficult Q3 OpEx comparableQ3 FY26

    Impacts EBITDA margin trends.

    Mitigation: Factored into Q3 adjusted EBITDA margin guidance (slightly below Q2 levels).

    What to watch in Q3 FY26

    5

    Q3 Adjusted EBITDA Margin

    Q3 FY26
    Current29.5%
    Targetslightly below Q2 levels

    Why it matters

    Indicates the impact of strategic growth investments and revenue seasonality on profitability.

    We are affecting Q3 adjusted EBITDA margins to be slightly below Q2 levels, driven by slightly lower revenue on an absolute basis and the impact of modest strategic growth investments.

    Q&A highlights

    6

    Are new products having a tangible impact on top-line growth or margins, and what are the limitations or priorities for bolt-on acquisitions across the portfolio?

    New products are absolutely driving growth, evidenced by the accelerating core growth over the last four quarters, with examples like Fluke CertiFiber Max and AI-enabled innovations. For bolt-ons, the focus is on the strongest platforms like Fluke and ASP, skewing towards differentiated hardware businesses, while software bolt-ons are possible but require specific attributes like proprietary data and regulatory lock-in to fit financial criteria.

    You're going to see us skew towards strongest brands. On your point about software, I mentioned this, I think, a few calls ago, we like the software brands we have because of the attributes they have around proprietary data and regulatory lock-in and two-sided networks. And so if we're looking to bolt-on anything, that thing has to have those attributes to light as well.

    asked by Scott Davis · answered by Olumide Soroye

    3 min read8 chapters

    Detailed Narrative

    01

    Fortive Accelerated Strategy Execution

    Fortive continues to execute its accelerated strategy across three pillars: faster profitable organic growth, disciplined capital allocation, and building investor trust. Investments in innovation, commercial efforts, and recurring customer value are contributing to accelerated growth, margin expansion, and earnings performance. The company remains confident in its medium-term financial framework and value creation opportunity, with strong performance ahead of expectations for the fourth consecutive quarter.

    02

    Innovation Driving Growth

    Innovation velocity is translating into faster growth across the portfolio. Fluke's innovation funnel is expanding with new products aligned to strategic areas like data centers, defense, and early-career technicians, with CertiFiber Max exceeding expectations. In facilities and asset lifecycle solutions, AI-enabled predictive maintenance tools are being expanded. Gordian's Flash AI solution is in production across strategic accounts, cutting construction cost estimate time from days to minutes.

    03

    Commercial Momentum and Recurring Revenue

    Commercial efforts are focused on faster-growing end markets and regions. Fluke's investments in data center expertise drove incremental demand, and strong momentum continues in India. Gordian is reinforcing its competitive differentiation through contractor engagement. Recurring revenue growth was strong across both segments, with Fluke seeing strong performance in services and software, and ASP consumables and services showing solid growth in every major region.

    04

    Disciplined Capital Allocation

    Fortive remains disciplined in its capital allocation. In Q2, the company deployed approximately $200 million to share repurchases, bringing the total since the spin-off to nearly $2 billion, representing 38 million shares or 11% of diluted shares outstanding. A small bolt-on acquisition of UV Smart was completed, expanding ASP's portfolio. Capital priorities remain organic growth investment, accretive bolt-on M&A, share repurchases, and a modest growing dividend.

    05

    Fluke Performance and Data Center Opportunity

    Fluke delivered another strong quarter with broad-based strength across product lines and geographies, driven by both price and volume. North America remained the strongest growth driver, with strong point-of-sale data. While Europe was affected by macroeconomic uncertainty🌐, APAC and Latin America posted solid growth. Fluke's new products, like CertiFiber Max, are specifically targeting data center commissioning and maintenance, creating pull-through for its broader portfolio and leveraging existing strength in this high-velocity end market.

    06

    Advanced Healthcare Solutions (AHS) Strength

    The AHS segment delivered solid revenue growth, driven by strong demand for healthcare consumables, services, and software across Latin America, APAC, and North America. Low-temperature sterilization capital demand improved modestly and contributed to growth, indicating a recovery in hospital capital spending. The segment's software products continue to perform well, particularly in gastrointestinal case documentation solutions.

    07

    Gross Margin Dynamics and Strategic Investments

    Consolidated adjusted gross margin was down year-over-year, primarily due to product mix dynamics, specifically outsized growth in certain lower-margin products within Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). In AHS, this was partly due to resumed growth in ASP's capital equipment and strategic investments against larger accounts. Despite this, operating leverage and discrete structural cost savings contributed to adjusted EBITDA margin expansion.

    08

    AI Integration and Impact

    Fortive has been leveraging AI for seven years, starting with an AI center of excellence. This head start has allowed rapid deployment of AI features across its six software brands, delivering measurable returns for customers by saving costs and improving productivity. Examples include AI-enabled predictive maintenance in ServiceChannel and Accruent, and Flash AI in Gordian. The investment level has been manageable due to existing infrastructure and partnerships, contributing to the strong performance of the software businesses.

    AI-generated summary of the company’s earnings call. Not investment advice.